At a glance
- Originator SICOR
- Class Anti-ischaemics; Antiarrhythmics; Antithrombotics; Ischaemic heart disorder therapies; Small molecules
- Mechanism of Action Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ischaemic heart disorders; Myocardial infarction; Unstable angina pectoris
Most Recent Events
- 26 Nov 2007 Discontinued - Phase-I for Ischaemic heart disorders in USA (unspecified route)
- 26 Nov 2007 Discontinued - Phase-I for Myocardial infarction in USA (unspecified route)
- 26 Nov 2007 Discontinued - Phase-I for Unstable angina pectoris in USA (unspecified route)